Skip to main content

Research Repository

Advanced Search

γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study

Morling, Joanne R.; Fallowfield, Jonathan A.; Williamson, Rachel M.; Robertson, Christine M.; Glancy, Stephen; Guha, Indra Neil; Strachan, Mark W.J.; Price, Jackie F.

Authors

JOANNE MORLING JOANNE.MORLING@NOTTINGHAM.AC.UK
Clinician Scientist Fellowin Public Health

Jonathan A. Fallowfield Jonathan.Fallowfield@ed.ac.uk

Rachel M. Williamson

Christine M. Robertson

Stephen Glancy

NEIL GUHA neil.guha@nottingham.ac.uk
Professor of Hepatology

Mark W.J. Strachan

Jackie F. Price



Abstract

© 2015, The Author(s). Aims/hypothesis: We examined the association of prevalent and incident cardiovascular disease (CVD) with chronic liver disease in a cohort of community-based people with type 2 diabetes, in order to clarify the relationship between these two important conditions. Methods: 1,066 participants with type 2 diabetes aged 60–75 years underwent assessment of a range of liver injury markers (non-specific injury, steatosis, steatohepatitis, fibrosis, portal hypertension). Individuals were followed up for incident cardiovascular events. Results: At baseline there were 370/1,033 patients with prevalent CVD, including 317/1,033 with coronary artery disease (CAD). After a mean follow-up of 4.4years there were 44/663 incident CVD events, including 27/663 CAD events. There were 30/82 CVD-related deaths. Risk of dying from or developing CVD was no higher in participants with steatosis than in those without (HR 0.90; 95% CI 0.40, 2.00; p > 0.05). The only notable relationship was with γ-glutamyltransferase (GGT) (incident CVD: adjusted HR for doubling GGT 1.24 [95% CI 0.97, 1.59] p = 0.086; incident CAD: adjusted HR 1.33 [95% CI 1.00, 1.78] p = 0.053), suggesting that in our study population, chronic liver disease may have little effect on the development of, or mortality from, CVD. Conclusions/interpretation: An independent association between GGT and CVD warrants further exploration as a potentially useful addition to current cardiovascular risk prediction models in diabetes. However, overall findings failed to suggest that there is a clinical or pathophysiological association between chronic liver disease and CVD in elderly people with type 2 diabetes.

Journal Article Type Article
Publication Date 2015-07
Journal Diabetologia
Print ISSN 0012-186X
Electronic ISSN 1432-0428
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 58
Issue 7
Pages 1484-1493
APA6 Citation Morling, J. R., Fallowfield, J. A., Williamson, R. M., Robertson, C. M., Glancy, S., Guha, I. N., …Price, J. F. (2015). γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study. Diabetologia, 58(7), 1484-1493. https://doi.org/10.1007/s00125-015-3575-y
DOI https://doi.org/10.1007/s00125-015-3575-y
Keywords Cardiovascular diseases; Community-based; Epidemiology; Fatty liver ; γ-Glutamyltransferase ; Type 2 diabetes mellitus
Publisher URL https://link.springer.com/article/10.1007%2Fs00125-015-3575-y
Related Public URLs http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473275/
Copyright Statement Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0

Files

Morling 2015 Diabetologia.pdf (255 Kb)
PDF

Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0





You might also like



Downloadable Citations

;